Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse Nurr1 ELISA Kit (AC3784)
Cat.#: ASET-2373
Specifications
Description Mouse Nurr1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Nurr1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.87 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 25-400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1251 Human PICALM ELISA Kit (AC2662) Quantitative inquiry ASET-1723 Rat beta nerve growth factor ELISA Kit (AC3134) Quantitative inquiry ASET-2445 Rat Kiss1 ELISA Kit (AC3856) Quantitative inquiry ASET-1980 Human Serine Racemase ELISA Kit (AC3391) Quantitative inquiry ASET-1811 Human Substance P ELISA Kit (AC3222) Quantitative inquiry ASET-2235 Human PTN ELISA Kit (AC3646) Quantitative inquiry ASET-2161 Mouse Niemann Pick C1 ELISA Kit (AC3572) Quantitative inquiry ASET-1983 Mouse SRD5A1 ELISA Kit (AC3394) Quantitative inquiry ASET-1010 Human HMGN1 ELISA Kit (AC2421) Quantitative inquiry ASET-1173 Mouse Wnt8b ELISA Kit (AC2584) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket